在线国产一区二区_成人黄色片在线观看_国产成人免费_日韩精品免费在线视频_亚洲精品美女久久_欧美一级免费在线观看

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Q and A with CEO

Healthy approach to business

By Zhong Nan | China Daily | Updated: 2017-08-04 07:54
Share
Share - WeChat

Werner Baumann, CEO and chairman of the board of management at Bayer AG. [Photo provided to China Daily]

Innovation appears to be embedded in Werner Baumann's DNA. It is part of his makeup and the driving force behind Bayer AG's philosophy in China.

As CEO of the sprawling German multinational life sciences company, the 55-year-old is committed to change. He also respects tradition.

"It is always nice to come to China and see how fast things are evolving and developing in the country, and in our group," Baumann said.

"We have been in China since 1882, and our future growth prospects are closely linked to the market," he added.

During the next five years, Bayer will continue to invest in pharmaceuticals, crop science and consumer health.

By 2020, the company will have injected 1.4 billion yuan ($207 million) into its manufacturing plant in Kunming, Yunnan province. Eventually, this will become a global hub for traditional Chinese medicine and Western-style pharmaceuticals.

"Our aim is to ensure access to healthcare products," Baumann said.

Bayer is comprised of around 301 consolidated companies in 78 countries across the world, with its global headquarters in Leverkusen, Germany. The group has about 115,000 employees worldwide, according to its website.

Annual revenue in China was more than 5 billion euros ($5.85 billion) in 2016, while the company's global sales in the second quarter were about 12.2 billion euros, a jump of 1.9 percent compared to the same period last year.

"Pharmaceuticals posted sales growth of 4.4 percent to 4.3 billion euros," the group's corporate website stated.

Looking ahead, Baumann told China Daily about his hands-on approach, the company's plans here and his love for Do-It-Yourself, or DIY.

How do you visualize China's economic future?

The country has set 2020 as the target year to realize the "centenary goal" of building a moderately prosperous society (in an all-round way). This involves doubling its 2010 GDP (gross domestic product) and the 2010 per capita income of urban and rural residents by then.

In order to do this, China must maintain a steady medium-to-high rate of economic growth, while prioritizing better quality and more sustainable expansion.

With an increasing and aging population, it will be a challenge, both globally and in China, to ensure an adequate supply of safe, nutritious food, and access to healthcare products.

How do you assess Bayer's prospects here?

We have invested in China during many years and have an extensive footprint here. The country is the world's second largest economy, accounting for more than 30 percent of global economic growth in 2016.

We are confident we will be able to seize market opportunities in accordance with our business strategy and the needs of Chinese society. Our product portfolio and solutions are well suited to help generate sustainable growth.

What are your company's plans in China and for the group globally?

We believe that innovation and the ability to adapt quickly to a changing external environment are crucial drivers to invigorate and enhance economies. It will also help us stay competitive.

Our mission, "Bayer-Science for a Better Life", puts innovation at the heart of our company. We innovate to meet our customers' and patients' needs, and to adapt to fast-changing circumstances. Therefore, China's push for more innovation fits our business and market positioning.

What is your business philosophy?

There are two things. First, always do what is right and be fully committed and confident when opportunities arise. Always manage risk responsibly.

The second point, in business and in life, is you must surround yourself with people you can trust. That is absolutely essential.

At Bayer, I am blessed and very grateful for the trust that I have been given, and for the fantastic people that I have the privilege to work with.

How do you plan to develop markets related to the Belt and Road Initiative?

The Belt and Road Initiative is exciting and bold. Since it was proposed in 2013, China has made progress in achieving its aim of building a trade and infrastructure network to connect Asia with Europe and Africa along various ancient trade routes. We believe that more connectivity and exchanges between countries will generally create opportunities for economic and social growth. Bayer has been engaged in China since 1882, and our future growth prospects are closely linked to the market here.

What is the secret behind your business success in China?

I would have to say deep knowledge of the market here and the ongoing commitment to the country even through difficult times. You need the ability to anticipate trends and market developments, as well as key government initiatives.

You also have to roll out innovative product portfolios and customized solutions that meet the needs of Chinese consumers. A strong leadership team guarantees the strategy's implementation and helps achieve the company's goals.

We have qualified and passionate employees in China.

What is your biggest achievement in China as CEO of Bayer?

There are many areas in China which allow us to make a real contribution to the welfare of the Chinese people. One big trend is the shift in focus of the country's economy toward innovation and entrepreneurship. This suits Bayer as innovation is at the heart of our company.

We use advanced technology at our production sites in China. For example, the 100 million euros expansion of our pharmaceutical packaging plant in Beijing features industry-leading manufacturing efficiency, robotics, automation and digitalization.

Also, an oral multi-kinase inhibitor for the treatment of metastatic colorectal cancer and gastrointestinal tumors was launched in China this year. In the agribusiness, Bayer has rolled out nine new crop protection products in the country, covering rice, corn, wheat, vegetables and fruits between 2015-16.

More recently, we introduced a traditional Chinese medicine product, which we produce at our plant in Kunming.

How do you get along with local partners?

We have long-term relationships with leading institutions and universities in China, including a strategic collaboration program with Peking University to promote translational research in drug discovery.

We also have a research program with the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences in the fields of new synthetic methodology, natural product derivatives and organometallic chemistry.

There is, of course, a research agreement with the Shanghai Institutes for Biological Sciences to improve wheat yields. Other partnerships involve our e-commerce connections and startups through our digital health incubator program.

How do you motivate your international team?

Our employees have tremendous opportunities at Bayer. We also embrace diversity and have aspirational targets in terms of gender and nationality.

I also want to mention Bayer's employer brand, "Passion to Innovate-Power to Change". This indicates that if you have the passion to innovate, we will give you the power to change.

What is an effective leadership strategy for running a company in China?

Bayer is well positioned for the future and has the ability to address long-term challenges in society. At the same time, we can take advantage of related business opportunities in China.

What is needed to support success in this market is innovation, cutting-edge products and technologies, as well as relentless customer focus and strong governance.

How do you cope with setbacks?

Life is never plain sailing. You will always face hardships and challenges. They are simply parts of life. Naturally, the same applies to the development of companies.

First, you must understand market trends. The market is changing and you should be brave enough to challenge the status quo and try new things.

Second, you need a strong team to further expand the business, based on joint expertise and experience. Third, reliable partnerships are also necessary. And, you should always focus on the customer.

What are your hobbies and how do you spend your weekends?

Frankly, when I'm not on business trips, I simply enjoy spending time with my family. We live in Krefeld, a town near Dusseldorf. It is actually my home town where my parents used to have a bakery. Now, I am passionate about crafts and Do-It-Yourself. Whenever something needs to be repaired in the house I do it-except electrical issues.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 亚洲国产高清视频 | 国产福利在线视频 | 欧美在线免费 | 91精品国产色综合久久不卡98口 | 亚洲人成一区 | 亚洲精品国产第一综合99久久 | 久久久久久a女人 | 国产成人精品在线观看 | 污视频网站在线观看免费 | 精品国产不卡一区二区三区 | 成人综合在线观看 | 国产日韩欧美一区 | 久久综合一区二区三区 | 欧美激情网站 | 亚洲大成色 | av午夜电影 | 久久精品国产亚洲a∨蜜臀 性视频网站免费 | 亚洲视频三区 | 日韩欧美国产一区二区 | 国产主播一区 | 亚洲精品乱码久久久久久蜜桃91 | 免费黄色福利网站 | 久草视频在线播放 | 人人射人人插 | 国产区视频在线观看 | 国产乱码精品一区二区三区五月婷 | 男女羞羞视频免费观看 | 久久伊人影院 | 国产精品99久久久久久久久 | 日本欧美在线观看 | 操操日| 精品少妇一区二区三区在线播放 | 一级黄色影片在线观看 | 欧美视频1区 | 一区二区久久 | 免费观看一级特黄欧美大片 | 999久久国产| 美女一区二区三区在线观看 | 国产精品18hdxxxⅹ在线 | 亚洲人成人一区二区在线观看 | 亚洲影视一区 |